U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07797023) titled 'Comparative Efficacy of Soft Tissue Mobilization and Ulnar Nerve-Specific Strengthening Exe... Read More
U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07796776) titled 'The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness W... Read More
Singapore, Sept. 2 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More
Singapore, Sept. 2 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More
U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07798297) titled 'Transitional Intervention for Hyperacusis in Autism' on Aug. 24. Brief Summary: The main g... Read More
Singapore, Sept. 2 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07797192) titled 'Evaluation of Allergenicity by HRIPT and Phototest' on Aug. 24. Brief Summary: This clinic... Read More
Singapore, Sept. 2 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07797335) titled 'AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body... Read More
Singapore, Sept. 2 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More